These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 6345744

  • 1. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
    Tetzlaff RF.
    J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
    [No Abstract] [Full Text] [Related]

  • 2. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A.
    Pol Tyg Lek; 1983; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract] [Full Text] [Related]

  • 3. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M.
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract] [Full Text] [Related]

  • 4. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization.
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [Abstract] [Full Text] [Related]

  • 5. Quality by design, process analytical technology, GMP and regulatory affairs.
    Çelik M.
    Pharm Dev Technol; 2018 Jul; 23(6):553. PubMed ID: 29785887
    [No Abstract] [Full Text] [Related]

  • 6. [Basic trends in research on the standardization and control of drugs].
    Smirnov MI.
    Farm Zh; 1977 Jul; 32(4):31-5. PubMed ID: 913544
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA.
    Food Drug Law J; 1997 Jul; 52(1):67-82. PubMed ID: 10346711
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical investigation of new drugs.
    N Engl J Med; 1967 Nov 23; 277(21):1148-9. PubMed ID: 4861565
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Technological and raw-material factors that determine drug quality and the efficiency of their production].
    Muravev IO.
    Farm Zh; 1977 Nov 23; 32(4):18-21. PubMed ID: 913539
    [No Abstract] [Full Text] [Related]

  • 14. Validation of tangential flow filtration (TFF) systems.
    Michaels SL.
    J Parenter Sci Technol; 1991 Nov 23; 45(5):218-23. PubMed ID: 1753311
    [No Abstract] [Full Text] [Related]

  • 15. Response to the applicability of proposed large volume parenteral regulations to small volume parenteral drug products.
    Bull Parenter Drug Assoc; 1976 Nov 23; 30(6):265-79. PubMed ID: 1000103
    [No Abstract] [Full Text] [Related]

  • 16. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994 Nov 23; 48(1):4-6. PubMed ID: 8004417
    [No Abstract] [Full Text] [Related]

  • 17. [Information systems for phase III and IV clinical trials].
    Alamercery Y, Begaud, Chastang, Derzko, Dupuis Y, Gomeni R, Go L, Lemarie, Mery, Wartelle.
    J Pharmacol; 1986 Nov 23; 17 Suppl 1():12-8. PubMed ID: 3747536
    [No Abstract] [Full Text] [Related]

  • 18. [Scientific achievements in the field of pharmaceutical analysis and the ways of improving the control of drug quality in the 10th Five-Year Plan].
    Tentsova AI, Senov PL, Belikov VG.
    Farm Zh; 1977 Nov 23; 32(4):13-8. PubMed ID: 913538
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical testing of drugs].
    Begemann H.
    Med Klin; 1973 May 04; 68(18):569-71. PubMed ID: 4576603
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.